This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
whole | blood | 1079 |
red | blood | 855 |
red | cell | 619 |
red | cells | 416 |
- | time | 282 |
- | transfusion | 265 |
- | cell | 179 |
- | test | 170 |
high | risk | 144 |
- | blood | 137 |
first | time | 134 |
- | risk | 131 |
positive | results | 124 |
positive | samples | 108 |
specific | antibodies | 81 |
high | levels | 70 |
human | blood | 69 |
negative | blood | 69 |
clinical | studies | 64 |
- | treatment | 63 |
- | cells | 62 |
positive | blood | 61 |
- | antibodies | 58 |
severe | cases | 57 |
human | plasma | 57 |
high | level | 56 |
higher | risk | 56 |
- | day | 55 |
positive | result | 55 |
- | group | 53 |
- | year | 53 |
low | levels | 53 |
other | blood | 53 |
respiratory | system | 51 |
positive | antibody | 47 |
negative | results | 47 |
- | platelet | 47 |
positive | donors | 46 |
significant | antibodies | 46 |
other | studies | 45 |
other | factors | 44 |
pulmonary | disease | 44 |
respiratory | disease | 44 |
different | blood | 43 |
clinical | samples | 40 |
high | blood | 40 |
new | blood | 39 |
- | patients | 38 |
low | risk | 38 |
- | donor | 37 |
- | effects | 37 |
cardiac | disease | 36 |
mean | platelet | 36 |
low | blood | 35 |
- | p | 34 |
new | donors | 34 |
- | donors | 34 |
- | antibody | 34 |
low | level | 32 |
other | patients | 32 |
severe | disease | 32 |
such | cases | 32 |
higher | levels | 32 |
human | platelet | 31 |
- | patient | 30 |
first | day | 30 |
other | groups | 29 |
positive | effect | 29 |
positive | cells | 29 |
normal | blood | 29 |
- | plasma | 29 |
mean | time | 28 |
such | patients | 27 |
different | levels | 26 |
different | methods | 26 |
negative | result | 26 |
significant | risk | 26 |
significant | effect | 25 |
positive | patients | 25 |
new | method | 25 |
first | study | 25 |
- | level | 25 |
- | infection | 25 |
- | system | 24 |
cardiac | diseases | 24 |
first | group | 24 |
- | tests | 23 |
- | unit | 23 |
first | transfusion | 23 |
negative | patients | 23 |
positive | test | 23 |
mean | blood | 22 |
clinical | disease | 22 |
- | factor | 21 |
negative | effects | 21 |
negative | samples | 21 |
normal | plasma | 21 |
small | sample | 21 |
different | groups | 21 |
clinical | cases | 20 |
clinical | study | 20 |
specific | antibody | 20 |
specific | treatment | 19 |
negative | donors | 18 |
specific | blood | 18 |
clinical | transfusion | 18 |
lower | blood | 18 |
acute | blood | 17 |
first | blood | 17 |
other | diseases | 17 |
severe | transfusion | 17 |
higher | blood | 16 |
pulmonary | blood | 16 |
normal | levels | 16 |
normal | platelet | 16 |
first | case | 16 |
- | products | 16 |
cardiac | patients | 16 |
different | patient | 16 |
- | tested | 15 |
acute | disease | 15 |
human | platelets | 15 |
lower | levels | 15 |
lower | risk | 15 |
more | units | 15 |
other | day | 15 |
positive | donor | 15 |
severe | infections | 15 |
mean | plasma | 14 |
other | tests | 14 |
more | time | 14 |
- | groups | 14 |
large | blood | 14 |
important | factor | 14 |
- | sample | 14 |
severe | infection | 13 |
respiratory | infections | 13 |
respiratory | diseases | 13 |
other | cases | 13 |
positive | tests | 13 |
other | methods | 13 |
different | plasma | 13 |
low | platelet | 13 |
different | cell | 13 |
- | product | 13 |
- | effect | 13 |
first | days | 13 |
negative | antibody | 12 |
such | studies | 12 |
specific | test | 12 |
severe | patients | 12 |
other | risk | 12 |
more | patients | 12 |
important | factors | 12 |
human | patients | 12 |
higher | plasma | 12 |
- | levels | 12 |
negative | test | 11 |
small | blood | 11 |
respiratory | infection | 11 |
pulmonary | infection | 11 |
positive | effects | 11 |
positive | cases | 11 |
other | plasma | 11 |
other | cells | 11 |
human | cells | 11 |
negative | effect | 11 |
human | disease | 11 |
higher | platelet | 11 |
first | results | 11 |
acute | cases | 11 |
- | platelets | 11 |
- | disease | 11 |
mean | levels | 11 |
other | patient | 10 |
normal | level | 10 |
other | disease | 10 |
other | infections | 10 |
lower | level | 10 |
other | transfusion | 10 |
other | treatments | 10 |
severe | blood | 10 |
more | days | 10 |
other | group | 10 |
larger | studies | 10 |
common | disease | 10 |
common | antibody | 10 |
- | units | 10 |
clinical | patients | 10 |
clinical | effects | 10 |
clinical | diseases | 10 |
acute | infection | 10 |
- | years | 10 |
highest | level | 10 |
highest | risk | 9 |
specific | diseases | 9 |
other | donors | 9 |
other | antibodies | 9 |
new | methods | 9 |
important | blood | 9 |
high | platelet | 9 |
high | plasma | 9 |
first | patient | 9 |
different | time | 9 |
clinical | plasma | 9 |
clinical | effect | 9 |
- | systems | 9 |
more | blood | 8 |
whole | transfusion | 8 |
specific | tests | 8 |
small | risk | 8 |
significant | effects | 8 |
positive | platelets | 8 |
positive | group | 8 |
new | donor | 8 |
negative | group | 8 |
- | method | 8 |
mean | cell | 8 |
low | plasma | 8 |
large | group | 8 |
large | cell | 8 |
different | times | 8 |
different | studies | 8 |
clinical | results | 8 |
clinical | factors | 8 |
- | days | 8 |
other | products | 7 |
significant | blood | 7 |
respiratory | systems | 7 |
pulmonary | infections | 7 |
pulmonary | diseases | 7 |
other | samples | 7 |
other | units | 7 |
normal | group | 7 |
cardiac | risk | 7 |
new | antibodies | 7 |
negative | infections | 7 |
large | study | 7 |
high | cell | 7 |
new | system | 7 |
small | cell | 6 |
other | risks | 6 |
other | systems | 6 |
positive | products | 6 |
significant | factor | 6 |
significant | platelet | 6 |
specific | group | 6 |
specific | disease | 6 |
specific | factors | 6 |
normal | donor | 6 |
specific | risks | 6 |
whole | study | 6 |
whole | system | 6 |
other | cell | 6 |
positive | sample | 6 |
new | platelet | 6 |
first | result | 6 |
new | patients | 6 |
- | factors | 6 |
clinical | case | 6 |
common | donor | 6 |
different | cells | 6 |
clinical | treatment | 6 |
human | infections | 6 |
large | platelets | 6 |
large | sample | 6 |
larger | study | 6 |
more | products | 6 |
new | cases | 6 |
significant | transfusion | 5 |
new | level | 5 |
new | products | 5 |
new | risk | 5 |
other | effects | 5 |
negative | donor | 5 |
other | platelet | 5 |
other | treatment | 5 |
such | donors | 5 |
small | group | 5 |
small | groups | 5 |
small | patients | 5 |
small | study | 5 |
specific | platelet | 5 |
such | diseases | 5 |
such | transfusions | 5 |
new | group | 5 |
human | infection | 5 |
more | transfusions | 5 |
different | disease | 5 |
- | case | 5 |
- | study | 5 |
acute | effects | 5 |
more | donors | 5 |
clinical | infection | 5 |
common | factor | 5 |
acute | transfusion | 5 |
different | effects | 5 |
different | products | 5 |
high | antibody | 5 |
higher | level | 5 |
human | studies | 5 |
low | factor | 5 |
mean | treatment | 5 |
more | plasma | 4 |
more | samples | 4 |
negative | p | 4 |
new | antibody | 4 |
new | test | 4 |
normal | cells | 4 |
other | case | 4 |
positive | units | 4 |
whole | group | 4 |
specific | results | 4 |
specific | risk | 4 |
such | products | 4 |
such | samples | 4 |
such | study | 4 |
such | tests | 4 |
mean | % | 4 |
whole | sample | 4 |
more | infections | 4 |
significant | results | 4 |
larger | patient | 4 |
different | diseases | 4 |
larger | groups | 4 |
- | result | 4 |
acute | infections | 4 |
cardiac | cases | 4 |
cardiac | effects | 4 |
clinical | sample | 4 |
common | diseases | 4 |
different | days | 4 |
- | infections | 4 |
different | donors | 4 |
human | diseases | 4 |
different | platelet | 4 |
first | product | 4 |
first | unit | 4 |
first | year | 4 |
higher | donor | 4 |
different | factors | 4 |
pulmonary | cells | 3 |
positive | transfusions | 3 |
positive | patient | 3 |
others | donors | 3 |
other | sample | 3 |
other | donor | 3 |
normal | factor | 3 |
new | tests | 3 |
normal | donors | 3 |
non | tested | 3 |
new | treatment | 3 |
new | risks | 3 |
new | product | 3 |
new | infection | 3 |
negative | units | 3 |
negative | products | 3 |
pulmonary | system | 3 |
specific | method | 3 |
severe | risk | 3 |
significant | antibody | 3 |
whole | plasma | 3 |
whole | donor | 3 |
such | treatment | 3 |
such | infections | 3 |
such | blood | 3 |
such | antibodies | 3 |
specific | patients | 3 |
specific | patient | 3 |
specific | groups | 3 |
specific | factor | 3 |
specific | cell | 3 |
smaller | blood | 3 |
small | case | 3 |
significant | factors | 3 |
significant | disease | 3 |
negative | studied | 3 |
high | donor | 3 |
negative | plasma | 3 |
first | cases | 3 |
different | test | 3 |
different | sample | 3 |
different | group | 3 |
different | case | 3 |
different | antibody | 3 |
commonest | antibodies | 3 |
common | risk | 3 |
common | blood | 3 |
common | antibodies | 3 |
clinical | tests | 3 |
clinical | blood | 3 |
- | treatments | 3 |
- | times | 3 |
- | plasmas | 3 |
- | methods | 3 |
different | treatment | 3 |
negative | infection | 3 |
high | disease | 3 |
large | studies | 3 |
high | sample | 3 |
negative | cells | 3 |
more | years | 3 |
more | donor | 3 |
mean | p | 3 |
lower | transfusion | 3 |
low | antibody | 3 |
mean | level | 3 |
large | donor | 3 |
large | cells | 3 |
important | transfusion | 3 |
important | risk | 3 |
human | cell | 3 |
highest | levels | 3 |
high | transfusion | 3 |
new | treatments | 2 |
positive | study | 2 |
positive | platelet | 2 |
positive | case | 2 |
positive | antibodies | 2 |
other | infection | 2 |
normal | results | 2 |
normal | platelets | 2 |
more | times | 2 |
new | transfusion | 2 |
new | patient | 2 |
new | disease | 2 |
new | cell | 2 |
negative | sample | 2 |
negative | platelets | 2 |
more | transfusion | 2 |
pulmonary | group | 2 |
positive | transfusion | 2 |
small | transfusion | 2 |
pulmonary | samples | 2 |
red | plasma | 2 |
more | platelet | 2 |
whole | time | 2 |
such | units | 2 |
such | systems | 2 |
such | risks | 2 |
such | product | 2 |
such | methods | 2 |
specific | transfusion | 2 |
specific | methods | 2 |
specific | effects | 2 |
small | donor | 2 |
significant | time | 2 |
significant | levels | 2 |
significant | level | 2 |
severe | diseases | 2 |
more | studies | 2 |
new | study | 2 |
mean | risk | 2 |
common | group | 2 |
first | test | 2 |
first | sample | 2 |
different | transfusion | 2 |
different | tests | 2 |
different | effect | 2 |
different | donor | 2 |
common | transfusion | 2 |
common | effects | 2 |
higher | infection | 2 |
clinical | test | 2 |
clinical | patient | 2 |
clinical | levels | 2 |
clinical | groups | 2 |
cardiac | cells | 2 |
acute | treatment | 2 |
mean | day | 2 |
first | treatment | 2 |
clinical | platelet | 2 |
higher | patient | 2 |
- | samples | 2 |
lowest | level | 2 |
higher | risks | 2 |
lower | platelet | 2 |
lower | day | 2 |
low | results | 2 |
larger | samples | 2 |
larger | sample | 2 |
lower | cell | 2 |
important | treatment | 2 |
important | method | 2 |
human | samples | 2 |
human | factors | 2 |
human | factor | 2 |
highest | blood | 2 |
important | study | 2 |
human | donors | 2 |
other | results | 1 |
other | tested | 1 |
other | system | 1 |
other | study | 1 |
other | studied | 1 |
other | factor | 1 |
other | platelets | 1 |
normal | samples | 1 |
normal | patient | 1 |
other | unit | 1 |
normal | p | 1 |
other | time | 1 |
positive | infections | 1 |
others | infection | 1 |
others | products | 1 |
others | risk | 1 |
others | studied | 1 |
others | studies | 1 |
positive | cell | 1 |
positive | infection | 1 |
positive | p | 1 |
positive | plasma | 1 |
positive | studies | 1 |
positives | results | 1 |
normal | day | 1 |
normal | groups | 1 |
negative | disease | 1 |
normal | cell | 1 |
newer | methods | 1 |
pulmonary | effects | 1 |
more | platelets | 1 |
more | results | 1 |
more | systems | 1 |
more | tests | 1 |
more | treatment | 1 |
more | treatments | 1 |
negative | case | 1 |
negative | cases | 1 |
negative | groups | 1 |
negative | patient | 1 |
negative | platelet | 1 |
negative | studies | 1 |
negative | study | 1 |
negative | tests | 1 |
negative | unit | 1 |
new | cells | 1 |
new | diseases | 1 |
new | infections | 1 |
new | plasma | 1 |
new | platelets | 1 |
new | sample | 1 |
new | studies | 1 |
new | systems | 1 |
new | unit | 1 |
pulmonary | cell | 1 |
whole | treatment | 1 |
pulmonary | patients | 1 |
specific | cells | 1 |
specific | donor | 1 |
specific | effect | 1 |
specific | infections | 1 |
specific | plasma | 1 |
specific | products | 1 |
specific | studies | 1 |
specific | time | 1 |
such | antibody | 1 |
such | cells | 1 |
such | donor | 1 |
such | effects | 1 |
such | factors | 1 |
such | group | 1 |
such | groups | 1 |
such | infection | 1 |
such | patient | 1 |
such | plasma | 1 |
such | results | 1 |
such | time | 1 |
such | transfusion | 1 |
whole | p | 1 |
whole | patient | 1 |
whole | platelets | 1 |
whole | test | 1 |
more | infection | 1 |
specific | day | 1 |
smaller | units | 1 |
pulmonary | plasma | 1 |
smaller | samples | 1 |
pulmonary | platelet | 1 |
pulmonary | systems | 1 |
red | patients | 1 |
respiratory | cases | 1 |
respiratory | effects | 1 |
respiratory | factors | 1 |
respiratory | studies | 1 |
severe | factor | 1 |
severe | patient | 1 |
severe | test | 1 |
severest | cases | 1 |
significant | infection | 1 |
significant | plasma | 1 |
significant | risks | 1 |
small | diseases | 1 |
small | effect | 1 |
small | effects | 1 |
small | patient | 1 |
small | plasma | 1 |
small | platelets | 1 |
small | studies | 1 |
small | units | 1 |
smaller | cells | 1 |
smaller | plasma | 1 |
smaller | sample | 1 |
more | patient | 1 |
human | donor | 1 |
more | groups | 1 |
different | antibodies | 1 |
different | infections | 1 |
different | p | 1 |
different | patients | 1 |
different | results | 1 |
different | samples | 1 |
different | studys | 1 |
different | systems | 1 |
different | units | 1 |
first | antibody | 1 |
first | donor | 1 |
first | level | 1 |
first | products | 1 |
first | resulted | 1 |
first | samples | 1 |
first | studies | 1 |
first | tested | 1 |
high | risks | 1 |
higher | % | 1 |
higher | case | 1 |
higher | factor | 1 |
higher | sample | 1 |
higher | test | 1 |
highest | plasma | 1 |
highest | platelet | 1 |
highest | time | 1 |
different | cases | 1 |
common | tests | 1 |
more | factor | 1 |
common | product | 1 |
- | risks | 1 |
- | sampled | 1 |
- | studied | 1 |
- | studies | 1 |
- | timed | 1 |
acute | patients | 1 |
acute | plasma | 1 |
acute | risk | 1 |
anti | factor | 1 |
anti | platelet | 1 |
cardiac | donor | 1 |
cardiac | donors | 1 |
cardiac | group | 1 |
cardiac | patient | 1 |
clinical | infections | 1 |
clinical | risk | 1 |
clinical | unit | 1 |
clinical | units | 1 |
common | infection | 1 |
common | infections | 1 |
common | method | 1 |
common | methods | 1 |
common | p | 1 |
common | patient | 1 |
common | platelet | 1 |
human | antibodies | 1 |
human | antibody | 1 |
human | case | 1 |
human | cases | 1 |
largest | blood | 1 |
largest | case | 1 |
largest | group | 1 |
largest | risk | 1 |
low | % | 1 |
low | patients | 1 |
low | sample | 1 |
low | transfusion | 1 |
low | treatment | 1 |
lower | antibody | 1 |
lower | group | 1 |
lower | groups | 1 |
lower | plasma | 1 |
lower | product | 1 |
lowest | risk | 1 |
mean | case | 1 |
mean | donor | 1 |
mean | patient | 1 |
mean | resulting | 1 |
mean | times | 1 |
mean | transfusion | 1 |
more | antibodies | 1 |
more | case | 1 |
more | cases | 1 |
more | effect | 1 |
larger | time | 1 |
larger | results | 1 |
larger | product | 1 |
important | effects | 1 |
human | level | 1 |
human | plasmas | 1 |
human | product | 1 |
human | risk | 1 |
human | study | 1 |
human | transfusion | 1 |
human | transfusions | 1 |
human | units | 1 |
humans | plasma | 1 |
humans | result | 1 |
important | day | 1 |
important | infection | 1 |
larger | platelets | 1 |
important | plasma | 1 |
important | result | 1 |
important | results | 1 |
important | studies | 1 |
important | system | 1 |
large | groups | 1 |
large | plasma | 1 |
large | samples | 1 |
large | transfusion | 1 |
larger | blood | 1 |
larger | donor | 1 |
whole | year | 1 |